The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 08, 2013
Filed:
May. 28, 2008
Keith R. Hildebrand, Houlton, WI (US);
Michael R. Ujhelyi, Maple Grove, MN (US);
Xiaohong Zhou, Plymouth, MN (US);
Daniel C. Sigg, St. Paul, MN (US);
Linda M. Page, Woodbury, MN (US);
Keith R. Hildebrand, Houlton, WI (US);
Michael R. Ujhelyi, Maple Grove, MN (US);
Xiaohong Zhou, Plymouth, MN (US);
Daniel C. Sigg, St. Paul, MN (US);
Linda M. Page, Woodbury, MN (US);
Medtronic, Inc., Minneapolis, MN (US);
Abstract
A sympatholytic cardiovascular agent delivered by a drug delivery pump to a central nervous system site to alleviate symptoms of acute or chronic cardiac insult or impaired cardiac performance. The drug delivery pump can be external or implantable infusion pump (IIP) coupled with a drug infusion catheter extending to the site. A patient activator can command delivery of a dosage and/or an implantable heart monitor (IHM) coupled with a sensor can detect physiologic parameters associated with cardiac insult or impaired cardiac performance and trigger dosage delivery. The IIP and IHM can be combined into a single implantable medical device (IMD) or can constitute separate IMDs that communicate by any of known communication mechanisms. The sympatholytic cardiovascular agent is one of the group consisting of an alpha-adrenergic agonist and an alpha2-adrenergic agonist (e.g., clonidine, p-aminoclonidine, guanabenz, lidamidine, tizanidine, moxonidine, methyldopa, xylazine, guanfacine, detomidine, medetomidine, and dexmedetomidine).